Delivery Order SPE2DB20D3111-SPE2DB25FA5SV

Award Date 11/21/24
Potential Completion Date 11/22/24
Potential Value $1.9K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award is for the delivery of telmisartan 40 mg tablets to the Defense Logistics Agency (DLA). The contract was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The firm-fixed-price contract is valued at $1,871.31 and has an ultimate completion date of November 22, 2024. It was awarded on November 21, 2024 as a delivery order, without any set-aside designation. AmerisourceBergen holds a significant $999,999,999...
This federal contract award is for the delivery of Telmisartan 40 mg tablets (30-count) to the Defense Logistics Agency (DLA). The $1,605.98 firm fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, on March 21, 2024, with a completion date of March 22, 2024. The contract is not designated as a set-aside. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, to supply Telmisartan 20 mg tablets. The $6,665.42 firm-fixed-price delivery order is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC enables the efficient procurement of a wide range of pharmaceutical products and...
This federal contract award is for the delivery of 4,563,681,036 units of Telmisartan 40 mg tablets to the Defense Logistics Agency (DLA), a defense agency under the U.S. Department of Defense. The contract has a ceiling value of $1,433.08 and is a firm fixed-price delivery order awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract has a period of performance through February 16, 2024. No set-aside designation was used for this award. AmerisourceBergen Drug...
This federal contract award is for the delivery of Telmisartan 40 mg tablets to the Defense Logistics Agency (DLA). The $2,944.54 firm fixed price delivery order was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical to provide a comprehensive range of pharmaceutical products and...
This federal contract award, valued at $1,323.50, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the delivery of Telmisartan 40 mg tablets. The contract has an ultimate completion date of February 19, 2025 and is a firm fixed-price delivery order. The award is not designated as a set-aside contract. AmerisourceBergen, a major pharmaceutical distributor and healthcare solutions provider, holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop...
This federal contract award is for the delivery of Telmisartan 80 mg tablets, a cardiovascular medication, to the Defense Logistics Agency (DLA). The $4,599.81 firm-fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, on November 8, 2024, with a completion date of November 12, 2024. The contract is not designated as a set-aside. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a subsidiary of Cencora, Inc., is for the delivery of Telmisartan 40 mg tablets. The firm-fixed-price contract, valued at $1,103.80, has a completion date of January 23, 2023. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00, which serves as the primary vehicle for the company to deliver a comprehensive...
This is a federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA). The contract is a Delivery Order valued at $1,751.57 for the delivery of Telmisartan 40 mg tablets. The contract has a period of performance through November 28, 2023 and is a Firm Fixed Price arrangement. AmerisourceBergen has established Indefinite Delivery Contracts (IDCs) with both the DLA Troop Support Medical and the...
This federal contract award is for the delivery of Telmisartan 40 mg tablets to the Defense Logistics Agency (DLA). The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a ceiling value of $1,629.46 and an ultimate completion date of October 30, 2024. This award is not designated as a set-aside contract. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop...
  • SPE2DB20D3111
    Indefinite Delivery Contract
  • SPE2DB20D3111-SPE2DB25FA5SV
    Delivery Order

This federal contract award is for the delivery of Telmisartan 40 mg tablets to the Defense Logistics Agency (DLA) by AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The firm fixed-price delivery order, valued at $1,866.14, has a period of performance through November 2024. It is associated with a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, which provides a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract does not have a set-aside designation, indicating open competition. In addition to the DLA contract, AmerisourceBergen also maintains a separate $750,000 IDC with the Department of Justice Federal Bureau of Investigation for similar medical products and prescription drugs.

Generated 2/20/25, 9:22 AM